Medication info

Aprogen Lansoprazole Capsule 30 mg

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Lansoprazole›30mg / 1 capsule
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
A hard capsule filled with white granules that are white to light brown, with a green upper part and white lower part.
Packaging
30, 100 capsules/bottle
Approval status
Expired

MFDS item code 201109827 · Approved 2011.11.10

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of gastric and duodenal ulcers, Helicobacter pylori eradication, gastroesophageal reflux disease, and gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice or more the amount of juice and drink immediately to ensure the full dose is taken. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg concomitantly with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. The usual starting dose for adults is 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90 mg per dose twice daily have been administered. If administering more than 120 mg daily, divide the dose. Because clearance of this medicine is reduced in elderly patients, dose adjustment is required. Do not exceed a daily dose of 30 mg. Because metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.
Child dose
Children and adolescents aged 12 ∼ 17 years - Short-term treatment of symptoms associated with nonerosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years - Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years - 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years - More than 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Treatment and prevention of gastric and duodenal ulcers, Helicobacter pylori eradication, gastroesophageal reflux disease, and gastric acid hypersecretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It is also effective for eradication treatment to prevent the recurrence of duodenal ulcers caused by Helicobacter pylori infection and for maintenance therapy after duodenal ulcer treatment. It helps in treating gastric ulcers caused by non-steroidal anti-inflammatory drugs and reduces the risk of occurrence. It is used for the treatment of symptoms related to gastroesophageal reflux disease and erosive esophagitis, as well as for maintenance therapy after treatment. Finally, it is effective for the treatment of pathological hypersecretion conditions such as Zollinger-Ellison syndrome. Therefore, it is widely used for treating various gastrointestinal diseases and associated symptoms.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice or more the amount of juice and drink immediately to ensure the full dose is taken. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg concomitantly with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. The usual starting dose for adults is 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90 mg per dose twice daily have been administered. If administering more than 120 mg daily, divide the dose. Because clearance of this medicine is reduced in elderly patients, dose adjustment is required. Do not exceed a daily dose of 30 mg. Because metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years - Short-term treatment of symptoms associated with nonerosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years - Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years - 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years - More than 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with known allergic reactions to specific components or in pregnant women. It is especially important not to use it if there has been a history of severe allergic reactions to this drug or similar medications. Caution should be exercised when using this medication in patients with poor liver function, elderly patients, nursing mothers, and children. If any severe allergic reactions or symptoms such as skin rash or difficulty in breathing occur while taking this medication, stop taking it immediately and consult a healthcare professional. Prolonged use may cause issues such as vitamin B12 deficiency or kidney dysfunction, so regular monitoring is necessary. Additionally, since this medication reduces gastric acid secretion, it may increase the risk of gastrointestinal bacterial infections, so if diarrhea or abdominal pain persists, consult a doctor. There may be drug interactions, so it is essential to inform healthcare professionals of any current medications. It is safest to avoid using this medication during pregnancy or breastfeeding, and if unavoidable, it should be used under the direction of a healthcare provider. In case of overdose, seek appropriate medical attention immediately. Keep out of reach of children and be careful not to change the container.

Side effects

Anaphylactic reaction, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, increased AST, increased ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, lethargy, neck stiffness, neck pain, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stools, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, gastric stone, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, bloating, gastric nodules, gastric fundic polyps, gastroenteritis, gastric duodenal bleeding, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disorders, glossitis, gingival bleeding, postprandial hypotension, colitis, vomiting, nausea, gastrointestinal candidiasis, rectal disorders, rectal bleeding, diabetes, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disorders, joint disorders, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia gravis, ptosis, synovitis, agitation, amnesia, anxiety, apathy, confusion, depression, dizziness, syncope, hallucinations, unilateral paralysis, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory disturbances, abnormal thoughts, convulsions, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory diminution, insomnia, sleep disturbance, drowsiness, tremor, acne, alopecia, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, altered olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, taste disturbance, tinnitus, constricted vision, urination disorder, renal colic, penile disorders, testicular disorders, urethral pain, polyuria, frequent urination, urinary retention, menstrual disorders, chest tenderness, chest expansion, gynecomastia, diabetes mellitus, hematuria, erectile dysfunction, kidney stones, hepatotoxicity, pancreatitis, taste abnormalities, aplastic anemia, leukopenia, neutropenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, speech disorders, urinary retention, increased AST, increased ALT, increased ALP, increased LDH, increased γ-GTP, malaise, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature of 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A hard capsule filled with white granules that are white to light brown, with a green upper part and white lower part.

Package unit

30, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.